Doctors test Tumor-Guided Pre-Surgery plan to boost esophageal cancer cure rates
NCT ID NCT06601309
Summary
This study is testing a personalized approach to pre-surgery treatment for locally advanced esophageal cancer. It aims to see if choosing a patient's pre-surgery therapy based on a specific tumor biomarker (called CPS score) can help more patients achieve a complete response, where no cancer is found after surgery. The goal is to improve long-term control of the disease and reduce the chance of it coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fujian Medical University Union Hospital
RECRUITINGFuzhou, Fujian, 350001, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.